Juvena Therapeutics Funding: $50M Raised, Series B (2026)
Juvena Therapeutics is based in Palo Alto, California. It has raised $50M in total funding. Latest round: Series B.
Juvena Therapeutics funding overview
Juvena Therapeutics is based in Palo Alto, California. Juvena Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2026. The round record for Juvena Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Bison Ventures, Eli Lilly and Company, Jefferson Life Sciences, Mubadala Capital, Manta Ray. 5 distinct backers are named across the disclosed rounds.
Juvena Therapeutics at a glance
Total raised
$50M
Latest round
Series B
Latest round date
January 2026
Headquarters
Palo Alto, California
Notable investors
Bison Ventures, Eli Lilly and Company, Jefferson Life Sciences, Mubadala Capital, Manta Ray
Frequently asked about Juvena Therapeutics funding
How much has Juvena Therapeutics raised?
Juvena Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Juvena Therapeutics?
Bison Ventures, Eli Lilly and Company, Jefferson Life Sciences, Mubadala Capital, Manta Ray are named among the investors backing Juvena Therapeutics.
What was the latest Juvena Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2026.
Where is Juvena Therapeutics based?
Juvena Therapeutics is based in Palo Alto, California.
When did Juvena Therapeutics last raise?
The last disclosed Juvena Therapeutics round closed in January 2026 at Series B.
Totals shown for Juvena Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Palo Alto and the investors behind them below.
